Accéder au contenu
Merck

Sodium bicarbonate: basically useless therapy.

Pediatrics (2008-10-03)
Judy L Aschner, Ronald L Poland
RÉSUMÉ

Common clinical practices often are unsupported by experimental evidence. One example is the administration of sodium bicarbonate to neonates. Despite a long history of widespread use, objective evidence that administration of sodium bicarbonate improves outcomes for patients in cardiopulmonary arrest or with metabolic acidosis is lacking. Indeed, there is evidence that this therapy is detrimental. This review examines the history of sodium bicarbonate use in neonatology and the evidence that refutes the clinical practice of administering sodium bicarbonate during cardiopulmonary resuscitation or to treat metabolic acidosis in the NICU.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Sigma-Aldrich
Bicarbonate de sodium, ACS reagent, ≥99.7%
Sigma-Aldrich
Bicarbonate de sodium, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Bicarbonate de sodium, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Bicarbonate de sodium solution, solution (7.5%), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Bicarbonate de sodium, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
Bicarbonate de sodium, BioXtra, 99.5-100.5%
USP
Bicarbonate de sodium, United States Pharmacopeia (USP) Reference Standard
Supelco
Bicarbonate de sodium solution, 0.1 M NaHCO3 in water, eluent concentrate for IC
Sigma-Aldrich
Bicarbonate de sodium, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Bicarbonate de sodium, −40-+140 mesh, ≥95%
Sigma-Aldrich
Bicarbonate de sodium, tested according to Ph. Eur.
Sigma-Aldrich
Sodium bicarbonate-12C, 99.9 atom % 12C